At close: November 27 at 9:44 PM GMT+1
Loading Chart for 4KF0.SG
DELL
- Previous Close
6.75 - Open
6.50 - Bid 6.45 x --
- Ask 7.00 x --
- Day's Range
6.45 - 6.65 - 52 Week Range
5.75 - 9.25 - Volume
0 - Avg. Volume
2 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Nov 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 4KF0.SG
View MorePerformance Overview: 4KF0.SG
Trailing total returns as of 11/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
4KF0.SG
17.83%
MSCI WORLD
19.44%
1-Year Return
4KF0.SG
17.83%
MSCI WORLD
25.84%
3-Year Return
4KF0.SG
17.83%
MSCI WORLD
20.86%
5-Year Return
4KF0.SG
17.83%
MSCI WORLD
64.38%
Compare To: 4KF0.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
6.45
-4.44%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.60
0.00%
Mkt Cap EUR 1.095B
Industry Drug Manufacturers—Specialty & Generic
1.3780
-6.51%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
8.92
+3.24%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
8.86
+3.57%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
8.72
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.79
+2.30%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.2320
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
3.6600
-2.40%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0805
-24.77%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0206
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: 4KF0.SG
View MoreValuation Measures
As of 9/19/2024
Market Cap
533.86M
Enterprise Value
570.69M
Trailing P/E
--
Forward P/E
181.82
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.76
Price/Book (mrq)
5.38
Enterprise Value/Revenue
3.17
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--